Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$2.97B |
| 2 |
Amazon
AMZN
|
+$1.93B |
| 3 |
GE Aerospace
GE
|
+$1.54B |
| 4 |
Apple
AAPL
|
+$1.29B |
| 5 |
Mercado Libre
MELI
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$3.46B |
| 2 |
Netflix
NFLX
|
+$2.03B |
| 3 |
Citigroup
C
|
+$1.92B |
| 4 |
Broadcom
AVGO
|
+$1.75B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.5% |
| 2 | Healthcare | 14.65% |
| 3 | Consumer Discretionary | 14.23% |
| 4 | Communication Services | 12.66% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Twilio
TWLO
$38.6B
| $91.4M | 0.02% |
347,019
+286,268
| +471% | +$85.6M |
|
|
SKX
327
DELISTED
Skechers
SKX
| $91.1M | 0.02% |
2,100,000
| – | – |
|
328
Pfizer
PFE
$153B
| $88.9M | 0.02% |
1,504,679
| – | – |
|
|
AVLR
329
DELISTED
Avalara, Inc.
AVLR
| $88.7M | 0.02% |
687,133
-151,385
| -18% | -$23.6M |
|
|
LGF.B
330
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $87.6M | 0.02% |
+5,689,295
| New | +$79.7M |
|
331
Silicon Laboratories
SLAB
$7.31B
| $86.5M | 0.02% |
419,000
-20,900
| -5% | -$3.85M |
|
332
Fortive
FTV
$18.4B
| $82.8M | 0.02% |
1,439,795
-3,236,737
| -69% | -$183M |
|
|
GDEN
333
DELISTED
Golden Entertainment
GDEN
| $82.1M | 0.02% |
1,625,000
+279,692
| +21% | +$13.9M |
|
|
AMED
334
DELISTED
Amedisys
AMED
| $81.8M | 0.02% |
505,620
+98,766
| +24% | +$15.9M |
|
|
AEPPZ
335
DELISTED
American Electric Power Company, Inc. Corporate Units
AEPPZ
| $81.6M | 0.02% |
1,552,043
| – | – |
|
336
Patria Investments
PAX
$1.83B
| $81.3M | 0.02% |
5,021,580
+100,000
| +2% | +$1.72M |
|
337
Leslie's
LESL
$7.07M
| $80.4M | 0.02% |
169,851
| – | – |
|
338
ResMed
RMD
$32.7B
| $79.3M | 0.02% |
+304,437
| New | +$79M |
|
339
Novartis
NVS
$290B
| $79M | 0.02% |
902,656
-384
| -0% | -$31.9K |
|
340
Semtech
SMTC
$12.7B
| $78.9M | 0.02% |
887,100
+39,000
| +5% | +$3.32M |
|
341
JFrog
FROG
$10.9B
| $78.2M | 0.02% |
2,632,599
+2,454,199
| +1,376% | +$80.9M |
|
|
CVT
342
DELISTED
Cvent Holding Corp. Common Stock
CVT
| $77.6M | 0.02% |
+10,000,000
| New | +$81.7M |
|
343
Bentley Systems
BSY
$10.5B
| $77.5M | 0.02% |
1,604,221
-1,718,074
| -52% | -$92.9M |
|
|
XM
344
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $77.1M | 0.02% |
2,177,797
-2,157,767
| -50% | -$83.9M |
|
345
Boston Properties
BXP
$11B
| $75.7M | 0.02% |
+657,137
| New | +$75.7M |
|
|
SCHW
346
Charles Schwab
SCHW
$189B
| $73.9M | 0.02% |
879,000
| – | – |
|
347
Levi Strauss
LEVI
$8.61B
| $73.8M | 0.02% |
2,950,000
| – | – |
|
|
MRSH
348
Marsh
MRSH
$89.4B
| $73.7M | 0.02% |
424,255
+406
| +0.1% | +$67.4K |
|
349
ManpowerGroup
MAN
$2.65B
| $73.7M | 0.02% |
757,461
-345
| -0% | -$34.6K |
|
350
Expensify
EXFY
$198M
| $73.3M | 0.02% |
+1,665,061
| New | +$67.8M |
|
Similar funds
Capital Research Global Investors's Q4 2021 Portfolio in Review
As of Q4 2021, Capital Research Global Investors held 470 positions worth $453B, up 5.6% from $429B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Research Global Investors's Q4 2021 filing shows 28 new, 171 increased, 189 reduced and 30 closed positions. Its largest new stake was Rivian: 25,755,740 shares worth $2.56B. The largest sale was Meta Platforms (Facebook), an estimated $3.46B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Capital Research Global Investors's largest Q4 2021 buy was Rivian: 25,755,740 shares worth $2.56B.
- Capital Research Global Investors added most to Amazon in Q4 2021, an estimated $1.93B increase.
- Capital Research Global Investors's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $3.46B.
- Capital Research Global Investors fully exited Allakos in Q4 2021, selling an estimated $520M.
- Capital Research Global Investors's ten largest holdings make up 30% of its $453B portfolio in Q4 2021.
- Capital Research Global Investors opened 28 new positions and closed 30 in Q4 2021.
- Capital Research Global Investors's portfolio value rose 5.6% quarter-over-quarter to $453B.
Based on Capital Research Global Investors's 13F filing for Q4 2021, filed 14 Feb 2022.